Front-line chronic lymphocytic leukemia: The role of chemoimmunotherapy

被引：5
|
作者：
Kim, Myung Sun [1 ,3 ]
Prasad, Vinay [2 ]
机构：
[1] Compass Oncol, Med Oncol Hematol, Portland, OR USA
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA
[3] Compass Oncol, Hematol Med Oncol, 5050 NE Hoyt St,Suite 256, Portland, OR 97213 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 04期
关键词：
D O I：
10.1002/ajh.26864
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：560 / 561
页数：2
相关论文
共 50 条
  • [1] Consolidation Treatment with Lenalidomide Following Front-line or Salvage Chemoimmunotherapy in Chronic Lymphocytic Leukemia
    Strati, Paolo
    Keating, Michael
    Burger, Jan
    O'Brien, Susan
    Wierda, William
    Estrov, Zeev
    Zacharian, Gracy
    Ferrajoli, Alessandra
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S299 - S300
  • [2] Consolidation treatment with lenalidomide following front-line or salvage chemoimmunotherapy in chronic lymphocytic leukemia
    Strati, Paolo
    Keating, Michael J.
    Burger, Jan A.
    O'Brien, Susan M.
    Wierda, William G.
    Estrov, Zeev
    Zacharian, Gracy
    Ferrajoli, Alessandra
    [J]. HAEMATOLOGICA, 2017, 102 (12) : 494 - 496
  • [3] Consolidation Treatment with Lenalidomide Following Front-line or Salvage Chemoimmunotherapy in Chronic Lymphocytic Leukemia
    Strati, Paolo
    Keating, Michael J.
    Burger, Jan A.
    O'Brien, Susan M.
    Wierda, William G.
    Estrov, Zeev
    Zacharian, Gracy
    Ferrajoli, Alessandra
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (10): : S12 - S13
  • [4] Front-Line Therapy for Chronic Lymphocytic Leukemia
    Desai, Sheetal
    Pinilla-Ibarz, Javier
    [J]. CANCER CONTROL, 2012, 19 (01) : 26 - 36
  • [5] Controversies in the front-line management of chronic lymphocytic leukemia
    Nabhan, Chadi
    Shanafelt, Tait D.
    Kay, Neil E.
    [J]. LEUKEMIA RESEARCH, 2008, 32 (05) : 679 - 688
  • [6] Lenalidomide and Rituximab Maintenance Therapy after Front-Line Induction Chemoimmunotherapy in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
    Chang, Julie E.
    Kenkre, Vaishalee P.
    Fletcher, Christopher D.
    Hall, Aric C.
    Callander, Natalie Scott
    Kim, Kyungmann
    Chen, Grace Yi
    Chambers, Kaitlin
    [J]. BLOOD, 2019, 134
  • [7] Ofatumumab as front-line therapy in untreated chronic lymphocytic leukemia
    Reagan, John L.
    Castillo, Jorge J.
    [J]. FUTURE ONCOLOGY, 2014, 10 (07) : 1147 - 1155
  • [8] Cost-Effectiveness Comparison between Ibrutinib, Chemotherapy, and Chemoimmunotherapy in Front-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
    Nabhan, Chadi
    Nero, Damion
    Lee, Choo Hyung
    Kish, Jonathan K.
    Mato, Anthony R.
    [J]. BLOOD, 2018, 132
  • [9] What Is Optimal Front-Line Therapy for Chronic Lymphocytic Leukemia in 2017?
    Benjamin N. Voorhies
    Deborah M. Stephens
    [J]. Current Treatment Options in Oncology, 2017, 18
  • [10] What Is Optimal Front-Line Therapy for Chronic Lymphocytic Leukemia in 2017?
    Voorhies, Benjamin N.
    Stephens, Deborah M.
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (02)
12345